FDA Hearing On ‘Hemp-Derived CBD’ Today | NORML
WASHINGTON, DC — Today, the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. “The rapidly evolving hemp-derived CBD marketplace sadly includes a number of bad faith actors selling the equivalent of modern day snake-oil,” said NORML Political Director Justin […]
FDA Hearing On ‘Hemp-Derived CBD’ Today | The Daily Chronic